517 related articles for article (PubMed ID: 31572393)
1. The Rise of
Van Dyke MCC; Thompson GR; Galgiani JN; Barker BM
Front Immunol; 2019; 10():2188. PubMed ID: 31572393
[TBL] [Abstract][Full Text] [Related]
2. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
Pappagianis D
Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636
[TBL] [Abstract][Full Text] [Related]
4. A vaccine against coccidioidomycosis is justified and attainable.
Cole GT; Xue JM; Okeke CN; Tarcha EJ; Basrur V; Schaller RA; Herr RA; Yu JJ; Hung CY
Med Mycol; 2004 Jun; 42(3):189-216. PubMed ID: 15283234
[TBL] [Abstract][Full Text] [Related]
5. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.
Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
Infect Immun; 2006 Jan; 74(1):516-27. PubMed ID: 16369008
[TBL] [Abstract][Full Text] [Related]
6. PM10 and Other Climatic Variables Are Important Predictors of Seasonal Variability of Coccidioidomycosis in Arizona.
Kollath DR; Mihaljevic JR; Barker BM
Microbiol Spectr; 2022 Apr; 10(2):e0148321. PubMed ID: 35319247
[TBL] [Abstract][Full Text] [Related]
7. A review of innate and adaptive immunity to coccidioidomycosis.
Hung CY; Hsu AP; Holland SM; Fierer J
Med Mycol; 2019 Feb; 57(Supplement_1):S85-S92. PubMed ID: 30690602
[TBL] [Abstract][Full Text] [Related]
8. Coccidioidomycosis: host response and vaccine development.
Cox RA; Magee DM
Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
[TBL] [Abstract][Full Text] [Related]
9. Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.
Hurtgen BJ; Hung CY
Methods Mol Biol; 2017; 1625():45-64. PubMed ID: 28584982
[TBL] [Abstract][Full Text] [Related]
10. Coccidioides immitis and posadasii; A review of their biology, genomics, pathogenesis, and host immunity.
Kirkland TN; Fierer J
Virulence; 2018; 9(1):1426-1435. PubMed ID: 30179067
[TBL] [Abstract][Full Text] [Related]
11. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis.
Delgado N; Xue J; Yu JJ; Hung CY; Cole GT
Infect Immun; 2003 Jun; 71(6):3010-9. PubMed ID: 12761077
[TBL] [Abstract][Full Text] [Related]
12. Local Population Structure and Patterns of Western Hemisphere Dispersal for Coccidioides spp., the Fungal Cause of Valley Fever.
Engelthaler DM; Roe CC; Hepp CM; Teixeira M; Driebe EM; Schupp JM; Gade L; Waddell V; Komatsu K; Arathoon E; Logemann H; Thompson GR; Chiller T; Barker B; Keim P; Litvintseva AP
mBio; 2016 Apr; 7(2):e00550-16. PubMed ID: 27118594
[TBL] [Abstract][Full Text] [Related]
13. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
[TBL] [Abstract][Full Text] [Related]
14. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
[TBL] [Abstract][Full Text] [Related]
15. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
Xue J; Hung CY; Yu JJ; Cole GT
Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity in coccidioidomycosis.
Cox RA; Magee DM
Res Immunol; 1998; 149(4-5):417-28; discussion 506-7. PubMed ID: 9720959
[No Abstract] [Full Text] [Related]
17. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
Herr RA; Hung CY; Cole GT
Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
[TBL] [Abstract][Full Text] [Related]
18. The Quest for a Vaccine Against Coccidioidomycosis: A Neglected Disease of the Americas.
Kirkland TN
J Fungi (Basel); 2016 Dec; 2(4):. PubMed ID: 29376949
[TBL] [Abstract][Full Text] [Related]
19. Immune Response to Coccidioidomycosis and the Development of a Vaccine.
Castro-Lopez N; Hung CY
Microorganisms; 2017 Mar; 5(1):. PubMed ID: 28300772
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell-based vaccine against coccidioides infection.
Awasthi S
Ann N Y Acad Sci; 2007 Sep; 1111():269-74. PubMed ID: 17363430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
